Left Atrial Appendage (LAA) Closure Devices Market Size 2022 | Boosting The Industry Growth, Covid-19 Impact, Dynamics and Trends, Global Forecast to 2031

According to the report published by Allied Market Research, Rise in number product approvals for atrial intervention, surge in atrial fibrillation, heart stroke cases, and hypertension-related diseases, and unhealthy lifestyle choices such as smoking drive the growth of the global left atrial appendage closure device market. In addition, rise in initiatives to raise awareness in untapped regions supplement the market growth. However, high cost of devices and availability of substitutes in the market restrain the growth. On the other hand, increase in adoption of cutting-edge technologies and improvement in implant effectiveness and procedural safety present opportunities in the market.

Covid-19 Scenario (Pre & Post Covid-19 Impact and Recovery Analysis (Estimates) is Covered in Left Atrial Appendage (LAA) Closure Devices Market Research Report )

• The Covid-19 pandemic made a considerable impact on the left atrial appendage closure devices market. The development and manufacturing activities of LAA closure devices were stopped due to lockdown restrictions and unavailability of sufficient raw materials.
• Moreover, hospitals and health authorities issued the cancellation or postponement of non-urgent procedures such as structural heart (SH) interventional surgeries for lowering down patient exposure to Covid-19 infection and preserve the capacity of ICUs for catering to Covid-infected patients.
• The limited availability of ICU beds and anaesthesiology led to considerable barriers in carrying out non-urgent structural heart interventions including LAA closure procedures and lowered use of LAA closure devices. This made a negative impact on the revenue.
• However, the market is expected to recover post-pandemic as SH interventional surgeries got back on track with vaccination programs and other preventive measures in place.

Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/3699

The Global Left Atrial Appendage Closure Device Market Size was valued at USD 1.3 billion in 2021, is poised to Reach USD 8.2 billion by 2031, witnessing a Growing CAGR of 21.0% from 2022 to 2031.

Left Atrial Appendage (LAA) Closure Device Market Key Segments:

By Product

• Epicardial LAA Closure Device
• Endocardial LAA Closure Device

By End User

• Hospitals
• Ambulatory Surgical Centers
• Heart Clinics

Leading Market Players

SentreHEART, Inc.
Boston Scientific Corporation
AtriCure, Inc.
Abbott Laboratories
Occlutech
Lifetech Scientific Corporation
Cardia, Inc.
Aegis Medical Group
Biosense Webster, Inc.
Johnson & Johnson Services, Inc.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3699

Based on region, North America held the largest market share in 2021, accounting for nearly half of the global left atrial appendage closure device market, and is projected to maintain its dominance in terms of revenue during the forecast period. This is due to widespread acceptance of advanced left atrial appendage closure devices, rise in incidence of atrial fibrillation, and well-developed healthcare infrastructure.

However, Asia-Pacific is projected to grow at the largest CAGR of 22.2% from 2022 to 2031, owing to high preference and acceptance of advanced technologies in closure devices in medical facilities in the region.

By Region Outlook

North America

⦁ U.S.
⦁ Canada
⦁ Mexico

Europe

⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe

Asia-Pacific

⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific

LAMEA

⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA

Our Market Research Solution Provides You Answer to Below Mentioned Question:

· Which are the driving factors responsible for the growth of market?
· Which are the roadblock factors of this market?
· What are the new opportunities, by which market will grow in the coming years?
· What are the trends of this market?
· Which are main factors responsible for new product launch?
· How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
· How big is the global & regional market in terms of revenue, sales and production?
· Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
· Which region has more opportunities

Get the Full Report: https://www.alliedmarketresearch.com/left-atrial-appendage-LAA-closure-device-market
Other Top Trending Reports:

Healthcare IT Market: https://www.alliedmarketresearch.com/healthcare-information-technology-market

Rheumatoid Arthritis Drugs Market: https://www.alliedmarketresearch.com/rheumatoid-arthritis-RA-drugs-market

Proteomics Market: https://www.alliedmarketresearch.com/proteomics-market

Medical Device Affairs Outsourcing Market: https://www.alliedmarketresearch.com/medical-device-affairs-outsourcing-market-A17667

Healthcare Gamification market: https://www.alliedmarketresearch.com/healthcare-gamification-market-A10988

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.